ANGPTL3 and type 2 diabetes mellitus: Research indicates that the expression levels of serum ANGPTL3 positively correlate with the stage of diabetic retinopathy (DR) in individuals with type 2 diabetes mellitus (T2DM), implying its potential use as a biomarker for tracking the progression of DR [6].